Respiratory Specialist For Merck Cananda Inc.
Merck Canada Inc.
South Saskatchewan
Merck's Respiratory (& Cardiovascular-Metabolic) Division.Primary focus = Allergy & Asthma. Secondary focus = Diabetes.Portfolio: Zenhale, Asmanex, Januvia, Janumet & Janumet (XR).Previous focus areas within Merck include Hypertension, Lipids, Pain & Diabetes. - Nasonex, Maxalt, Cozaar, Hyzaar, Ezetrol, Januvia & Janumet.Called upon primary care physicians, specialists, pharmacists, asthma & diabetes educators.Launched Zenhale and Asmanex into S. Sask., exceeding sales objectives.June 2014; Merck dissolves Sask. Respiratory Division, eliminating full-time positions.As of June 2014 ending, I was 121% to sales objective on a portfolio of $2.7 million.Exceeded objectives for 2010, 2011, 2012, 2013 & 2014.